The British Society for Heart Failure Autumn meeting, taking place virtually Nov. 26 – 27, will feature a keynote lecture highlighting the JACC: Heart Failure state-of-the-art review, Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF. Serving as the first lecturer, author John J.V. McMurray, MD, FACC, will present the keynote lecture, "21st Century Heart Failure: A Momentous First 2 Decades?" following introductory comments from JACC: Heart Failure Editor-in-Chief Christopher M. O’Connor, MD, MACC. The review paper, authored by McMurray; Kieran F. Docherty, Muthiah Vaduganathan, MD, MPH; and Scott D. Solomon, MD, examines the current understanding of the effects of sacubitril/valsartan and highlights expected developments over the next five years, including potential new indications for use. Learn more and register to attend.